| 1 | Abdominal Neoplasms | 30% |
| 2 | Head and Neck Neoplasms | 30% |
| 3 | Soft Tissue Neoplasms | 30% |
| 4 | Thoracic Neoplasms | 30% |
| 5 | Endocrine Gland Neoplasms | 23.1% |
| 6 | Eye Neoplasms | 23.1% |
| 7 | Nervous System Neoplasms | 23.1% |
| 8 | Bone neoplasms | 22.2% |
| 9 | Skin Neoplasms | 22.2% |
| 10 | Hematologic Neoplasms | 22.2% |
| 11 | Retroperitoneal Neoplasms | 22% |
| 12 | Splenic Neoplasms | 21.8% |
| 13 | Parathyroid Neoplasms | 21.4% |
| 14 | Thyroid Neoplasm | 21.4% |
| 15 | Thyroid carcinoma | 21.4% |
| 16 | Biliary Tract Diseases | 21.1% |
| 17 | Gastrointestinal Diseases | 21.1% |
| 18 | Liver diseases | 21.1% |
| 19 | Pancreatic Diseases | 21.1% |
| 20 | Proctocolitis | 20.9% |
| 21 | Acanthoma | 20.4% |
| 22 | Zollinger-Ellison syndrome | 20.2% |
| 23 | Biliary cirrhosis | 19.9% |
| 24 | Tracheal Neoplasms | 19.5% |
| 25 | Paraneoplastic Encephalomyelitis | 18.8% |
| 26 | Esophageal Neoplasms | 18.7% |
| 27 | Duodenitis | 18.6% |
| 28 | Ileitis | 18.6% |
| 29 | Erosive Duodenitis | 18.6% |
| 30 | Pancreatic Cyst | 18.5% |
| 31 | Mammary Neoplasms, Experimental | 18.4% |
| 32 | Choledochal Cyst | 17.9% |
| 33 | Dysentery | 17.9% |
| 34 | Enteritis | 17.9% |
| 35 | Enterocolitis | 17.9% |
| 36 | Esophageal and Gastric Varices | 17.9% |
| 37 | Esophagitis | 17.9% |
| 38 | Gastritis | 17.9% |
| 39 | Inflammatory Bowel Diseases | 17.9% |
| 40 | Peritoneal Neoplasms | 17.9% |
| 41 | Cholecystolithiasis | 17.9% |
| 42 | Pouchitis | 17.4% |
| 43 | Multiple Endocrine Neoplasia | 17.3% |
| 44 | Pancreatic Fistula | 17.3% |
| 45 | Thyroid Nodule | 17.2% |
| 46 | Colitis | 16.8% |
| 47 | Duodenogastric Reflux | 16.8% |
| 48 | Peptic Ulcer | 16.8% |
| 49 | Proctitis | 16.8% |
| 50 | Choledocholithiasis | 16.8% |
| 51 | Barrett Esophagus | 16.4% |
| 52 | Mouth Neoplasms | 16.4% |
| 53 | Central Nervous System Neoplasms | 16.4% |
| 54 | Vascular Neoplasms | 16.4% |
| 55 | Thymus Neoplasms | 16.4% |
| 56 | Genital Neoplasms, Female | 16.1% |
| 57 | Rectal Fistula | 16% |
| 58 | Anal Fistula | 16% |
| 59 | Mesenteric vascular insufficiency | 15.9% |
| 60 | Breast Neoplasms, Male | 15.9% |
| 61 | Triple Negative Breast Neoplasms | 15.9% |
| 62 | Crohn Disease | 15.8% |
| 63 | Duodenal Obstruction | 15.8% |
| 64 | Hamartoma | 15.8% |
| 65 | Neoplasms, Hormone-Dependent | 15.8% |
| 66 | Neoplasms, Multiple Primary | 15.8% |
| 67 | Paraneoplastic Syndromes | 15.8% |
| 68 | Precancerous Conditions | 15.8% |
| 69 | Neoplasms, Second Primary | 15.8% |
| 70 | Enterocolitis, Neutropenic | 15.8% |
| 71 | Necrotizing Enterocolitis | 15.8% |
| 72 | Esophageal Atresia | 15.7% |
| 73 | Intestinal Atresia | 15.7% |
| 74 | Mesenteric Vascular Occlusion | 15.7% |
| 75 | Carcinoma, Lobular | 15.7% |
| 76 | Intestinal Fistula | 15.6% |
| 77 | Enterocutaneous Fistula | 15.6% |
| 78 | Pancreatic Neoplasm | 15.3% |
| 79 | Duodenal Ulcer | 15.3% |
| 80 | Peptic Ulcer Perforation | 15.3% |
| 81 | Gastric ulcer | 15.3% |
| 82 | Colorectal Neoplasms | 15.1% |
| 83 | Bile Duct Diseases | 15% |
| 84 | Cholelithiasis | 15% |
| 85 | Chylous Ascites | 15% |
| 86 | Esophageal Diseases | 15% |
| 87 | Fatty Liver | 15% |
| 88 | Gastroenteritis | 15% |
| 89 | Hepatitis | 15% |
| 90 | Portal Hypertension | 15% |
| 91 | Intestinal Diseases | 15% |
| 92 | Liver Cirrhosis | 15% |
| 93 | Pancreatic Insufficiency | 15% |
| 94 | Pancreatitis | 15% |
| 95 | Pneumoperitoneum | 15% |
| 96 | Stomach Diseases | 15% |
| 97 | Focal Nodular Hyperplasia | 15% |
| 98 | Hepatic Insufficiency | 15% |
| 99 | Steatohepatitis | 15% |
| 100 | Thymoma | 14.7% |
| 101 | Meningioma | 14.6% |
| 102 | Colonic Pseudo-Obstruction | 14.5% |
| 103 | Pancreatic Pseudocyst | 14.3% |
| 104 | Testicular Neoplasms | 14.3% |
| 105 | Adenomatous Polyposis Coli | 14.2% |
| 106 | Fatty Liver, Alcoholic | 13.9% |
| 107 | Hepatitis, Alcoholic | 13.9% |
| 108 | Liver Cirrhosis, Alcoholic | 13.9% |
| 109 | Anus Neoplasms | 13.7% |
| 110 | Sigmoid Neoplasms | 13.7% |
| 111 | Appendicitis | 13.3% |
| 112 | Meningeal Neoplasms | 13.3% |
| 113 | Multiple Endocrine Neoplasia Type 1 | 13.2% |
| 114 | Adrenal Gland Neoplasms | 13% |
| 115 | Genital Neoplasms, Male | 13% |
| 116 | Uveal Neoplasms | 13% |
| 117 | Cecal Neoplasms | 13% |
| 118 | Duodenal Neoplasms | 13% |
| 119 | Urologic Neoplasms | 12.9% |
| 120 | Sebaceous Gland Neoplasms | 12.7% |
| 121 | Spinal Neoplasms | 12.7% |
| 122 | Bone Marrow Neoplasms | 12.7% |
| 123 | Carcinoma, Pancreatic Ductal | 12.6% |
| 124 | Acoustic Neuroma | 12.5% |
| 125 | Enterocolitis, Pseudomembranous | 12.4% |
| 126 | pseudomembranous colitis | 12.4% |
| 127 | Dysentery, Bacillary | 12.4% |
| 128 | Carcinoma 256, Walker | 12.3% |
| 129 | Colitis, Ischemic | 12.3% |
| 130 | Cecal Diseases | 12.2% |
| 131 | Cholangitis | 12.2% |
| 132 | Cholecystitis | 12.2% |
| 133 | Cholestasis | 12.2% |
| 134 | Colonic Diseases | 12.2% |
| 135 | Common Bile Duct Diseases | 12.2% |
| 136 | Esophageal Stenosis | 12.2% |
| 137 | Hepatitis, Chronic | 12.2% |
| 138 | Ileal Diseases | 12.2% |
| 139 | Intestinal Obstruction | 12.2% |
| 140 | Intestinal Perforation | 12.2% |
| 141 | Jejunal Diseases | 12.2% |
| 142 | Pneumatosis Cystoides Intestinalis | 12.2% |
| 143 | Rectal Diseases | 12.2% |
| 144 | Gastric Dilatation | 12.2% |
| 145 | Liver Failure | 12.2% |
| 146 | Pancreatitis, Chronic | 12.2% |
| 147 | Gastric outlet obstruction | 12.2% |
| 148 | Cronkhite-Canada Syndrome | 12.2% |
| 149 | Non-alcoholic Fatty Liver Disease | 12.2% |
| 150 | Chronic active hepatitis | 12.2% |
| 151 | Intestinal Polyposis | 12.2% |
| 152 | Appendiceal Neoplasms | 12.2% |
| 153 | Colonic Neoplasms | 12.2% |
| 154 | Rectal Neoplasms | 12.2% |
| 155 | Leukoplakia, Oral | 12.1% |
| 156 | Palatal Neoplasms | 12.1% |
| 157 | Paraneoplastic Cerebellar Degeneration | 12.1% |
| 158 | Meningeal Carcinomatosis | 11.8% |
| 159 | Carcinoma, Ehrlich Tumor | 11.7% |
| 160 | Dermoid Cyst | 11.7% |
| 161 | Carcinoma, Lewis Lung | 11.7% |
| 162 | Nose Neoplasms | 11.7% |
| 163 | Bile Duct Neoplasms | 11.6% |
| 164 | gallbladder neoplasm | 11.6% |
| 165 | Intestinal Neoplasms | 11.6% |
| 166 | Stomach Neoplasms | 11.6% |
| 167 | Cyst | 11.5% |
| 168 | Liver Diseases, Parasitic | 11.5% |
| 169 | Neoplastic Processes | 11.5% |
| 170 | Neoplastic Syndromes, Hereditary | 11.5% |
| 171 | Pregnancy Complications, Neoplastic | 11.5% |
| 172 | Vipoma | 11.4% |
| 173 | Neoplasms, Experimental | 11.3% |
| 174 | Leydig Cell Tumor | 11.3% |
| 175 | insulinoma | 11.3% |
| 176 | Gastrinoma | 11.2% |
| 177 | Glucagonoma | 11.2% |
| 178 | Hepatic Veno-Occlusive Disease | 11.1% |
| 179 | Peliosis Hepatis | 11.1% |
| 180 | Neoplasms, Neuroepithelial | 11.1% |
| 181 | Gliomatosis cerebri | 11.1% |
| 182 | Hepatopulmonary Syndrome | 11.1% |
| 183 | Retinoblastoma | 10.9% |
| 184 | Anus, Imperforate | 10.9% |
| 185 | Gastrointestinal Hemorrhage | 10.9% |
| 186 | Hemoperitoneum | 10.9% |
| 187 | Hepatomegaly | 10.9% |
| 188 | Mesenteric Panniculitis | 10.9% |
| 189 | Panniculitis, Peritoneal | 10.9% |
| 190 | Peritonitis | 10.9% |
| 191 | Peritoneal Fibrosis | 10.9% |
| 192 | Encapsulating Peritoneal Sclerosis | 10.9% |
| 193 | Anorectal Malformations | 10.9% |
| 194 | Cholestasis, Extrahepatic | 10.8% |
| 195 | Biliary Dyskinesia | 10.8% |
| 196 | Cholangitis, Sclerosing | 10.8% |
| 197 | Colonic Diseases, Functional | 10.8% |
| 198 | Esophageal motility disorders | 10.8% |
| 199 | Fecal Incontinence | 10.8% |
| 200 | Fecal Impaction | 10.8% |
| 201 | Intussusception | 10.8% |
| 202 | Mallory-Weiss Syndrome | 10.8% |
| 203 | Megacolon | 10.8% |
| 204 | Pyloric Stenosis | 10.8% |
| 205 | Liver Failure, Acute | 10.8% |
| 206 | Acalculous Cholecystitis | 10.8% |
| 207 | End Stage Liver Disease | 10.8% |
| 208 | Ileus | 10.8% |
| 209 | Meconium ileus | 10.8% |
| 210 | Biliary Fistula | 10.8% |
| 211 | Gastric Fistula | 10.8% |
| 212 | Ear Neoplasms | 10.8% |
| 213 | Eyelid Neoplasms | 10.8% |
| 214 | Lung Neoplasms | 10.8% |
| 215 | Pleural Neoplasms | 10.8% |
| 216 | Hepatic Vein Thrombosis | 10.8% |
| 217 | Liver Abscess | 10.8% |
| 218 | Budd-Chiari Syndrome | 10.8% |
| 219 | Optic Nerve Glioma | 10.8% |
| 220 | Medulloblastoma | 10.7% |
| 221 | Tuberculosis, Gastrointestinal | 10.7% |
| 222 | Neuroectodermal Tumors | 10.7% |
| 223 | Brain Neoplasms | 10.5% |
| 224 | Salivary Gland Neoplasms | 10.5% |
| 225 | Spinal Cord Neoplasms | 10.5% |
| 226 | Tongue Neoplasms | 10.5% |
| 227 | Gastrointestinal Stromal Tumors | 10.5% |
| 228 | Melanoma, Experimental | 10.5% |
| 229 | melanoma | 10.3% |
| 230 | Uterine Neoplasms | 10.3% |
| 231 | Vaginal Neoplasms | 10.3% |
| 232 | Vulvar Neoplasms | 10.3% |
| 233 | Uterine Cancer | 10.3% |
| 234 | Fallopian Tube Neoplasms | 10.3% |
| 235 | Pituitary Adenoma | 10.2% |
| 236 | Pituitary Neoplasms | 10.2% |
| 237 | Limbic Encephalitis | 10.2% |
| 238 | Massive Hepatic Necrosis | 10.2% |
| 239 | Esophageal Achalasia | 10.2% |
| 240 | Anal Fissure | 10.2% |
| 241 | Intestinal Pseudo-Obstruction | 10.2% |
| 242 | Irritable Bowel Syndrome | 10.2% |
| 243 | Superior Mesenteric Artery Syndrome | 10.2% |
| 244 | Emphysematous Cholecystitis | 10.2% |
| 245 | Neurogenic Bowel | 10.2% |
| 246 | Sphincter of Oddi Dysfunction | 10.2% |
| 247 | Anal Ulcer | 10.2% |
| 248 | Erythroplasia | 10% |
| 249 | Follicular cyst | 10% |
| 250 | leukemia | 10% |
| 251 | Mucocele | 10% |
| 252 | Neoplasms, Germ Cell and Embryonal | 10% |
| 253 | Neoplasms, Glandular and Epithelial | 10% |
| 254 | Pilonidal Cyst | 10% |
| 255 | Thyroglossal Cyst | 10% |
| 256 | Trophoblastic Neoplasms | 10% |
| 257 | Synovial Cyst | 10% |
| 258 | Germ Cell Cancer | 10% |
| 259 | Aberrant Crypt Foci | 10% |
| 260 | Hepatitis B, Chronic | 10% |
| 261 | Hepatitis C, Chronic | 10% |
| 262 | Leukemia, Experimental | 9.9% |
| 263 | Liver Abscess, Amebic | 9.9% |
| 264 | Peutz-Jeghers Syndrome | 9.8% |
| 265 | Carcinosarcoma | 9.7% |
| 266 | Hemangiosarcoma | 9.7% |
| 267 | Leukemia L1210 | 9.7% |
| 268 | Leukemia P388 | 9.7% |
| 269 | lymphangiosarcoma | 9.7% |
| 270 | Prolactinoma | 9.7% |
| 271 | Growth Hormone-Secreting Pituitary Adenoma | 9.7% |
| 272 | Adenoma, Acidophil | 9.6% |
| 273 | Ganglioneuroma | 9.6% |
| 274 | Glioma | 9.6% |
| 275 | Malignant Glioma | 9.6% |
| 276 | Bronchial Neoplasms | 9.5% |
| 277 | Esophageal Perforation | 9.4% |
| 278 | Hepatitis, Animal | 9.4% |
| 279 | Hepatitis, Viral, Human | 9.4% |
| 280 | Intestinal Diseases, Parasitic | 9.4% |
| 281 | Multiple Pulmonary Nodules | 9.4% |
| 282 | Supratentorial Neoplasms | 9.3% |
| 283 | Nephroblastoma | 9.3% |
| 284 | Sarcoma 180 | 9.3% |
| 285 | Carcinoid Tumor | 9.2% |
| 286 | Endometrial Neoplasms | 9.2% |
| 287 | Neurilemmoma | 9.2% |
| 288 | Hutchinson's Melanotic Freckle | 9.2% |
| 289 | Melanoma, Amelanotic | 9.2% |
| 290 | Sarcoma, Experimental | 9.2% |
| 291 | Deglutition Disorders | 9.1% |
| 292 | Lambert-Eaton Myasthenic Syndrome | 9.1% |
| 293 | Pharyngeal Neoplasms | 9% |
| 294 | Achlorhydria | 8.9% |
| 295 | Liver Cirrhosis, Experimental | 8.9% |
| 296 | Gastric Antral Vascular Ectasia | 8.9% |
| 297 | Liver Neoplasms, Experimental | 8.9% |
| 298 | Neoplasms, Radiation-Induced | 8.9% |
| 299 | ovarian neoplasm | 8.9% |
| 300 | Peptic Ulcer Hemorrhage | 8.8% |
| 301 | Gastroparesis | 8.8% |
| 302 | Pancreatitis, Alcoholic | 8.8% |
| 303 | Astrocytoma | 8.8% |
| 304 | Ependymoma | 8.8% |
| 305 | oligodendroglioma | 8.8% |
| 306 | Ganglioglioma | 8.8% |
| 307 | gliosarcoma | 8.8% |
| 308 | Anaplastic astrocytoma | 8.8% |
| 309 | Anaplastic Oligodendroglioma | 8.8% |
| 310 | Choriocarcinoma | 8.8% |
| 311 | Chemical and Drug Induced Liver Injury | 8.8% |
| 312 | Basal cell carcinoma | 8.8% |
| 313 | Carcinoma, Papillary | 8.8% |
| 314 | Squamous cell carcinoma | 8.8% |
| 315 | Chondrosarcoma | 8.8% |
| 316 | Craniopharyngioma | 8.8% |
| 317 | Cystadenoma | 8.8% |
| 318 | leiomyosarcoma | 8.8% |
| 319 | liposarcoma | 8.8% |
| 320 | Mesothelioma | 8.8% |
| 321 | synovial sarcoma | 8.8% |
| 322 | Neuroectodermal Tumor, Melanotic | 8.8% |
| 323 | Angiomyolipoma | 8.8% |
| 324 | Clear Cell Sarcoma of Soft Tissue | 8.8% |
| 325 | Alveolar Soft Part Sarcoma | 8.8% |
| 326 | Neuroendocrine Tumors | 8.8% |
| 327 | Central Nervous System Cysts | 8.8% |
| 328 | Sarcoma, Myeloid | 8.8% |
| 329 | Carcinoma, Basal Cell | 8.8% |
| 330 | Gastrointestinal Neoplasms | 8.7% |
| 331 | Liver neoplasms | 8.7% |
| 332 | Brain Stem Neoplasms | 8.7% |
| 333 | Penile Neoplasms | 8.7% |
| 334 | Prostatic Neoplasms | 8.7% |
| 335 | Malignant Carcinoid Syndrome | 8.7% |
| 336 | Adrenocortical carcinoma | 8.7% |
| 337 | Hepatocellular Adenoma | 8.6% |
| 338 | Polycythemia Vera | 8.5% |
| 339 | Hepatorenal Syndrome | 8.5% |
| 340 | Glioblastoma | 8.5% |
| 341 | Neuroblastoma | 8.5% |
| 342 | Glioblastoma Multiforme | 8.5% |
| 343 | Choroid Plexus Papilloma | 8.4% |
| 344 | granulosa cell tumor | 8.4% |
| 345 | Carcinoma, Ovarian Epithelial | 8.4% |
| 346 | Cystadenocarcinoma | 8.3% |
| 347 | Fibrosarcoma | 8.3% |
| 348 | Osteosarcoma | 8.3% |
| 349 | Mucoepidermoid Carcinoma | 8.3% |
| 350 | Ganglioneuroblastoma | 8.3% |
| 351 | Leukemia, Radiation-Induced | 8.3% |
| 352 | Mesoblastic Nephroma | 8.2% |
| 353 | Hemorrhoids | 8.1% |
| 354 | Autoimmune hepatitis | 8.1% |
| 355 | Adenofibroma | 8.1% |
| 356 | Fibroadenoma | 8.1% |
| 357 | Malignant Fibrous Histiocytoma | 8.1% |
| 358 | Opsoclonus-Myoclonus Syndrome | 8% |
| 359 | Afferent Loop Syndrome | 8% |
| 360 | Celiac Disease | 8% |
| 361 | Short Bowel Syndrome | 8% |
| 362 | Sprue, Tropical | 8% |
| 363 | Steatorrhea | 8% |
| 364 | Rectocele | 8% |
| 365 | Sprue | 8% |
| 366 | Diverticulitis | 7.9% |
| 367 | Dumping Syndrome | 7.9% |
| 368 | Rectal Prolapse | 7.9% |
| 369 | Bowen's Disease | 7.8% |
| 370 | Paraganglioma | 7.8% |
| 371 | Rhabdomyosarcoma | 7.8% |
| 372 | Giant Cell Tumor of Bone | 7.8% |
| 373 | Hypopharyngeal Neoplasms | 7.8% |
| 374 | Pleural Effusion, Malignant | 7.8% |
| 375 | Hypopharyngeal Cancer | 7.8% |
| 376 | Laryngeal neoplasm | 7.7% |
| 377 | Parotid Neoplasms | 7.6% |
| 378 | Prostatic Neoplasms, Castration-Resistant | 7.6% |
| 379 | Leukemia, Plasma Cell | 7.6% |
| 380 | Nelson Syndrome | 7.6% |
| 381 | Dermatofibrosarcoma | 7.6% |
| 382 | Dermatofibrosarcoma Protuberans | 7.6% |
| 383 | Tuberous Sclerosis | 7.6% |
| 384 | Renal Cell Carcinoma | 7.5% |
| 385 | Papillary Renal Cell Carcinoma | 7.5% |
| 386 | Pruritus Ani | 7.5% |
| 387 | Leukoplakia | 7.4% |
| 388 | Lymphocele | 7.4% |
| 389 | Laryngopharyngeal Reflux | 7.4% |
| 390 | Pheochromocytoma | 7.4% |
| 391 | Alveolar rhabdomyosarcoma | 7.4% |
| 392 | Adenoma | 7.3% |
| 393 | Ameloblastoma | 7.3% |
| 394 | Angiokeratoma | 7.3% |
| 395 | Bladder Neoplasm | 7.3% |
| 396 | Carcinoma | 7.3% |
| 397 | Chordoma | 7.3% |
| 398 | Cystic Fibrosis | 7.3% |
| 399 | Hemangioma | 7.3% |
| 400 | hemangiopericytoma | 7.3% |
| 401 | Kidney Neoplasm | 7.3% |
| 402 | Lymphangioma | 7.3% |
| 403 | Mesenchymoma | 7.3% |
| 404 | Nevus | 7.3% |
| 405 | Teratoma | 7.3% |
| 406 | Ureteral Neoplasms | 7.3% |
| 407 | Urethral Neoplasms | 7.3% |
| 408 | Hepatoblastoma | 7.3% |
| 409 | Mixed Tumor, Mullerian | 7.3% |
| 410 | Germinoma | 7.3% |
| 411 | Teratocarcinoma | 7.3% |
| 412 | Angiofibroma | 7.3% |
| 413 | Sarcoma | 7.3% |
| 414 | Epithelioma | 7.3% |
| 415 | Breast Cyst | 7.3% |
| 416 | Histiocytic Disorders, Malignant | 7.3% |
| 417 | Actinic keratosis | 7.3% |
| 418 | Mediastinal Cyst | 7.3% |
| 419 | Neoplasm Invasiveness | 7.3% |
| 420 | Neoplasm Metastasis | 7.3% |
| 421 | Neoplasm Recurrence, Local | 7.3% |
| 422 | Parovarian Cyst | 7.3% |
| 423 | Pericardial Cyst | 7.3% |
| 424 | Thymic Cyst | 7.3% |
| 425 | Carcinogenesis | 7.3% |
| 426 | Myxoid cyst | 7.3% |
| 427 | Metastasis | 7.3% |
| 428 | Tonsillar Neoplasms | 7.2% |
| 429 | Cerebellar Neoplasms | 7.2% |
| 430 | Carcinoma, Endometrioid | 7.2% |
| 431 | Fascioliasis | 7.1% |
| 432 | Lymphomatoid Granulomatosis | 7.1% |
| 433 | Myelitis, Transverse | 7.1% |
| 434 | Echinococcosis, Hepatic | 7.1% |
| 435 | Melena | 7.1% |
| 436 | Porphyrias, Hepatic | 7.1% |
| 437 | Congenital Hyperinsulinism | 7.1% |
| 438 | Carcinoid Heart Disease | 7% |
| 439 | Chemical and Drug Induced Liver Injury, Chronic | 7% |
| 440 | Reye Syndrome | 7% |
| 441 | Hematemesis | 6.9% |
| 442 | Composite Lymphoma | 6.9% |
| 443 | Hepatitis, Viral, Animal | 6.7% |
| 444 | Basal Cell Nevus Syndrome | 6.6% |
| 445 | Nasopharyngeal carcinoma | 6.6% |
| 446 | Hydatidiform Mole | 6.5% |
| 447 | Giardiasis | 6.5% |
| 448 | Hepatitis E | 6.5% |
| 449 | Hepatitis B | 6.4% |
| 450 | Hepatitis C | 6.4% |
| 451 | Diverticulum | 6.3% |
| 452 | Hepatitis A | 6.3% |
| 453 | Diverticulosis | 6.3% |
| 454 | Neurofibrosarcoma | 6.3% |
| 455 | Hepatic Encephalopathy | 6.2% |
| 456 | Adenocarcinoma | 6% |
| 457 | Carcinoma in Situ | 6% |
| 458 | Carcinoma, Transitional Cell | 6% |
| 459 | Phyllodes Tumor | 6% |
| 460 | Dysgerminoma | 6% |
| 461 | Hemangioendothelioma | 6% |
| 462 | Lipoma | 6% |
| 463 | Myoma | 6% |
| 464 | Myxoma | 6% |
| 465 | Neuroma | 6% |
| 466 | Papilloma | 6% |
| 467 | Pseudomyxoma Peritonei | 6% |
| 468 | Seminoma | 6% |
| 469 | Papillomatosis | 6% |
| 470 | Angiolipoma | 6% |
| 471 | Myelolipoma | 6% |
| 472 | Neoplasms, Bone Tissue | 6% |
| 473 | Neoplasms, Fibrous Tissue | 6% |
| 474 | Smooth Muscle Tumor | 6% |
| 475 | Adenomatosis, Pulmonary | 6% |
| 476 | Adenomatous Polyps | 6% |
| 477 | Carcinoma, Large Cell | 6% |
| 478 | Carcinoma, Small Cell | 6% |
| 479 | Desmoplastic Small Round Cell Tumor | 6% |
| 480 | Chondroma | 6% |
| 481 | Enchondroma | 6% |
| 482 | Endometrial Stromal Sarcoma | 5.9% |
| 483 | Nasopharyngeal Neoplasms | 5.8% |
| 484 | Lymphoma | 5.7% |
| 485 | Nesidioblastosis | 5.7% |
| 486 | Variegate Porphyria | 5.7% |
| 487 | Acute intermittent porphyria | 5.7% |
| 488 | Porphyria Cutanea Tarda | 5.7% |
| 489 | Lymphangioleiomyomatosis | 5.7% |
| 490 | Corpus Luteum Cyst | 5.7% |
| 491 | Ovarian Cysts | 5.7% |
| 492 | Denys-Drash Syndrome | 5.6% |
| 493 | Adenoid Cystic Carcinoma | 5.4% |
| 494 | fibroma | 5.4% |
| 495 | Fibromatosis | 5.4% |
| 496 | Osteoblastoma | 5.4% |
| 497 | Osteoma | 5.4% |
| 498 | Rhabdomyoma | 5.4% |
| 499 | Chondromatosis | 5.4% |
| 500 | Adenocarcinoma, Clear Cell | 5.4% |
| 501 | Cholangiocarcinoma | 5.4% |
| 502 | Cervical Intraepithelial Neoplasia | 5.4% |
| 503 | Hemangioblastoma | 5.4% |
| 504 | Lymphoma, Extranodal NK-T-Cell | 5.4% |
| 505 | Plasmacytoma | 5.4% |
| 506 | Malignant histiocytosis | 5.3% |
| 507 | Lymphatic Metastasis | 5.3% |
| 508 | Neoplasms, Unknown Primary | 5.3% |
| 509 | Leukemic Infiltration | 5.3% |
| 510 | Histiocytic sarcoma | 5.3% |
| 511 | Neoplasm Micrometastasis | 5.3% |
| 512 | Lactose Intolerance | 5.1% |
| 513 | Paranasal Sinus Neoplasms | 5.1% |
| 514 | Fibromatosis, Aggressive | 5.1% |
| 515 | Fibromatosis, Abdominal | 5.1% |
| 516 | Klatskin Tumor | 5.1% |
| 517 | Maxillary Sinus Neoplasms | 4.7% |
| 518 | Leukemia, Myelomonocytic, Chronic | 4.4% |
| 519 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.4% |
| 520 | Hodgkin Disease | 4.2% |
| 521 | Lymphoma, Non-Hodgkin | 4.2% |
| 522 | Polycystic Ovary Syndrome | 4.1% |
| 523 | Mastocytoma | 4% |
| 524 | Mastocytosis, Systemic | 3.9% |
| 525 | Leukemia, Myeloid, Chronic-Phase | 3.9% |
| 526 | Cryptosporidiosis | 3.9% |
| 527 | Rift Valley Fever | 3.7% |
| 528 | CREST Syndrome | 3.6% |
| 529 | Mastocytosis | 3.5% |
| 530 | Sturge-Weber Syndrome | 3.5% |
| 531 | Cell Transformation, Viral | 3.5% |
| 532 | Hemangioma, Cavernous | 3.5% |
| 533 | Primary amyloidosis | 3.5% |
| 534 | Leukemia, T-Cell | 3.4% |
| 535 | Leukemia, B-Cell | 3.4% |
| 536 | neurofibroma | 3.4% |
| 537 | Lymphoma, Follicular | 3.4% |
| 538 | T-Cell Lymphoma | 3.4% |
| 539 | Mantle cell lymphoma | 3.4% |
| 540 | Zellweger Syndrome | 3.4% |
| 541 | Hepatolenticular Degeneration | 3.1% |
| 542 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.1% |
| 543 | Leukemia, Large Granular Lymphocytic | 3.1% |
| 544 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3.1% |
| 545 | Lymphoma, T-Cell, Cutaneous | 3.1% |
| 546 | Lymphoma, AIDS-Related | 3.1% |
| 547 | Enteropathy-Associated T-Cell Lymphoma | 3.1% |
| 548 | Primary Effusion Lymphoma | 3.1% |
| 549 | Dupuytren Contracture | 3% |
| 550 | Urticaria Pigmentosa | 2.9% |
| 551 | Mycosis Fungoides | 2.9% |
| 552 | Lymphomatoid Papulosis | 2.9% |
| 553 | Plasmablastic lymphoma | 2.9% |
| 554 | Xeroderma Pigmentosum | 2.8% |
| 555 | Waldenstrom Macroglobulinemia | 2.6% |
| 556 | Multiple Myeloma | 2.6% |
| 557 | Burkitt Lymphoma | 2.2% |
| 558 | Sezary Syndrome | 2% |
| 559 | Radicular Cyst | 2% |